Fiera Capital Corp Novo Cure LTD Transaction History

Fiera Capital Corp

$31.6 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 22, 2024	SELL	$11.13 - $15.78 $3,561 - $5,049	-320 Reduced 1.83%	17,192 $256,000
Q4 2023 Feb 08, 2024	SELL	$11.13 - $15.78 $3,561 - $5,049	-320 Reduced 1.83%	17,192 $256,000
Q3 2023 Aug 22, 2024	BUY	$16.15 - $42.35 $282,818 - $741,633	17,512 New	17,512 $282,000
Q1 2023 Apr 26, 2023	SELL	$56.44 - $118.81 $17.3 Million - $36.5 Million	-307,118 Reduced 94.61%	17,512 $1.05 Million
Q4 2022 Feb 08, 2023	SELL	$63.98 - $85.37 $431,545 - $575,820	-6,745 Reduced 2.04%	324,630 $23.8 Million
Q3 2022 Nov 03, 2022	SELL	$67.99 - $89.57 $384,755 - $506,876	-5,659 Reduced 1.68%	331,375 $23.1 Million
Q2 2022 Aug 10, 2022	SELL	$56.6 - $89.9 $316,394 - $502,541	-5,590 Reduced 1.63%	337,034 $23.4 Million
Q1 2022 May 09, 2022	BUY	$60.15 - $84.52 $2,766 - $3,887	46 Added 0.01%	342,624 $28.4 Million
Q4 2021 Feb 08, 2022	SELL	$75.08 - $121.99 $1.44 Million - $2.34 Million	-19,181 Reduced 5.3%	342,578 $25.7 Million
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $647,415 - $1.08 Million	-5,573 Reduced 1.52%	361,759 $42 Million
Q2 2021 Aug 11, 2021	SELL	$130.4 - $225.58 $1.31 Million - $2.26 Million	-10,026 Reduced 2.66%	367,332 $21.8 Million
Q1 2021 May 11, 2021	SELL	$124.11 - $190.17 $1.01 Million - $1.55 Million	-8,151 Reduced 2.11%	377,358 $49.9 Million
Q4 2020 Feb 09, 2021	BUY	$112.16 - $174.14 $294,195 - $456,769	2,623 Added 0.69%	385,509 $66.7 Million
Q3 2020 Nov 12, 2020	SELL	$58.05 - $111.31 $745,942 - $1.43 Million	-12,850 Reduced 3.25%	382,886 $42.6 Million
Q2 2020 Aug 07, 2020	SELL	$57.2 - $74.41 $584,069 - $759,800	-10,211 Reduced 2.52%	395,736 $23.5 Million
Q1 2020 May 08, 2020	BUY	$57.05 - $95.75 $9.91 Million - $16.6 Million	173,680 Added 74.78%	405,947 $27.3 Million
Q4 2019 Feb 06, 2020	BUY	$68.3 - $93.8 $12.8 Million - $17.6 Million	187,313 Added 416.68%	232,267 $19.6 Million
Q3 2019 Nov 12, 2019	SELL	$61.86 - $97.8 $379,882 - $600,589	-6,141 Reduced 12.02%	44,954 $3.36 Million
Q2 2019 Aug 12, 2019	SELL	$42.22 - $63.23 $108,843 - $163,006	-2,578 Reduced 4.8%	51,095 $3.23 Million
Q1 2019 May 10, 2019	SELL	$31.96 - $56.12 $762,821 - $1.34 Million	-23,868 Reduced 30.78%	53,673 $2.59 Million
Q4 2018 Feb 12, 2019	BUY	$28.72 - $52.63 $2.23 Million - $4.08 Million	77,541 New	77,541 $2.6 Million

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$215 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$210 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$140 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$76.4 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$53.7 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account